HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bárbara Balandin Selected Research

Critical Illness (Critically Ill)

3/2021Multicenter study of ceftolozane/tazobactam for treatment of Pseudomonas aeruginosa infections in critically ill patients.
1/2016Emergence of linezolid-resistant coagulase-negative staphylococci in an intensive care unit.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bárbara Balandin Research Topics

Disease

3Infections
03/2021 - 01/2016
2Critical Illness (Critically Ill)
03/2021 - 01/2016
1Pseudomonas Infections
03/2021
1Septic Shock (Toxic Shock Syndrome)
01/2016
1Bacteremia
01/2016

Drug/Important Bio-Agent (IBA)

2Anti-Bacterial Agents (Antibiotics)IBA
03/2021 - 01/2016
1tazobactam drug combination ceftolozaneIBA
03/2021
1GlycopeptidesIBA
01/2016
1Linezolid (Zyvox)FDA Link
01/2016
1DaptomycinFDA Link
01/2016

Therapy/Procedure

3Therapeutics
03/2021 - 01/2016